How To Safely Use JAK Inhibitors in Patients with Inflammatory Bowel Disease
Crossref DOI link: https://doi.org/10.1007/s11938-025-00484-6
Published Online: 2025-10-15
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Loganantharaj, Nisha
Mishra, Kajali
Charabaty, Aline
Text and Data Mining valid from 2025-10-15
Version of Record valid from 2025-10-15
Article History
Received: 26 August 2025
Accepted: 26 September 2025
First Online: 15 October 2025
Declarations
:
: The authors declare no competing interests.